U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07226882) titled 'A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults' on Oct. 13.
Brief Summary: The purpose of this study is to learn about the safety and effects of the Lyme disease vaccine (called VLA15) when given at different time points.
This study is seeking participants who:
* are generally healthy and between 18 and 44 years of age,
* have never had a vaccine for Lyme disease before,
* are not currently taking, or haven't recently taken, medicines like chemotherapy, blood products, or blood thinners, and
* are not pregnant or breastfeeding and do not plan to become pregnant while receiving the ...